| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.0019 | 1 |